News & Updates
Filter by Specialty:
Ustekinumab safe, effective in Asians with severe plaque psoriasis
04 Mar 2022
byStephen Padilla
Ustekinumab, a human monoclonal antibody that binds to the p40 subunit of both interleukin (IL)-12 and IL-23, demonstrates effectiveness and safety in the treatment of multiethnic Asian patients with moderate to severe plaque psoriasis, according to a Singapore study.
Ustekinumab safe, effective in Asians with severe plaque psoriasis
04 Mar 2022
Minor changes in glucose levels first week after COVID-19 vaccine
03 Mar 2022
byRoshini Claire Anthony
Patients with type 1 diabetes mellitus (T1DM) may experience a temporary change in their blood glucose levels in the first week following COVID-19 vaccination, according to a small English study.
Minor changes in glucose levels first week after COVID-19 vaccine
03 Mar 2022
Effective PrEP averts further cost for HIV treatment
02 Mar 2022
Effective treatment with pre-exposure prophylaxis (PrEP) for HIV puts a cap on the additional cost patients should be willing to pay for long-acting injectable cabotegravir (CAB-LA), reports a US study.